About this trial
The goal of this study is to assess the performance of an artificial intelligence software (Osteo Signal) in detecting osteoporosis risk in adults 50 years and older. The main question it aims to answer is: What is the accuracy of the software in detecting osteoporosis risk on chest x-ray images as compared to the standard technique of dual-energy x-ray absorptiometry (DXA)? There is no direct involvement of participants in this study as it will use data from individuals who have already had a chest x-ray and a DXA scan taken in the past.
Eligibility criteria
Qualifiers
Age ≥50 years at the time of chest X-ray
Availability of
Posteroanterior (PA) Chest X-ray and
DXA scan with a valid T-score measurement where both the DXA scan and Chest x-ray examinations were performed within 6 months (182 days) of each other and
Disqualifiers
DXA scan inadequacy: Missing T-score from a technically inadequate scan.
PA Chest X-ray technical inadequacy: Non-PA projection, significant motion artefacts, inadequate visualisation of thoracic structures, or missing DICOM metadata.
Image format incompatibility: Non-DICOM format or corrupted image files that would prevent AI analysis
PA Chest X-ray > ±6 months from the date of the DXA scan.
Trial design
Treatments tested in this trial
- Osteo Signal